English

Chelsea Therapeutics International, Ltd.

EDGAR

CHTP Quarterly report (10-Q) · filed 2014-05-09

42 filing records in this dataset, filed from 2005-08-15 to 2014-05-09. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 37.1 million USD 2014-03-31 Source
Exact value

37090223 USD
Long-term debt including current maturities: Not available
Shares outstanding: 78.5 million shares 2014-03-31 Source
Exact value

78457126 shares

Reported share-count change

16.97% · 11.4 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

67075779 shares · 2013-03-31· Source
78457126 shares · 2014-03-31· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2014-05-09.

Financial data available through: 2013-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 10 of 11 periods available· newest 2013-12-31
Net income: 11 of 11 periods available· newest 2013-12-31
Operating cash flow: 9 of 11 periods available· newest 2013-12-31
Capital expenditure: 9 of 11 periods available· newest 2013-12-31
Total assets: 7 of 11 periods available· newest 2013-12-31
Total liabilities: 9 of 11 periods available· newest 2013-12-31
Current assets: 9 of 11 periods available· newest 2013-12-31
Current liabilities: 4 of 11 periods available· newest 2010-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2013-12-31
long term debt: No compatible figures in this window
Shares outstanding: 3 of 11 periods available· newest 2013-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 15.32 million

Prior period

−USD 31.74 million

2012-01-01 – 2012-12-31
Current period

−USD 16.42 million

2013-01-01 – 2013-12-31

Exact inputs and evidence

-16416233 − -31735909 = 15319676 USD

-31735909 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
-16416233 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Chelsea Therapeutics International, Ltd. · 2013-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Year-over-year change in Net income: 15319676 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -16416233 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#206241 Filing: 000114420414014836 Input fundies:NetIncome: -31735909 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#206102 Filing: 000114420414014836
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 24.36 million

Prior period

−USD 39.37 million

2012-01-01 – 2012-12-31
Current period

−USD 15.01 million

2013-01-01 – 2013-12-31

Exact inputs and evidence

-15007254 − -39365952 = 24358698 USD

-39365952 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
-15007254 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Chelsea Therapeutics International, Ltd. · 2013-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Year-over-year change in Operating cash flow: 24358698 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -15007254 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#286369 Filing: 000114420414014836 Input fundies:OperatingCashFlow: -39365952 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#286131 Filing: 000114420414014836
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-88.1%

Prior period

USD 25,260

2012-01-01 – 2012-12-31
Current period

USD 2,994

2013-01-01 – 2013-12-31

Exact inputs and evidence

2994 − 25260 = -22266 USD

25260 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
2994 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Chelsea Therapeutics International, Ltd. · 2013-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Year-over-year change in Capital expenditure: -22266 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 2994 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#287235 Filing: 000114420414014836 Input fundies:CapitalExpenditure: 25260 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#287041 Filing: 000114420414014836
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2004 2004-01-01 – 2004-12-31	−USD 3.02 million Exact value Exact value: -3016559 USD 2004-01-01 – 2004-12-31: -3016559 USD Inspect Net Income Open source Share or cite Citation for Net Income · Chelsea Therapeutics International, Ltd. · 2004-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Net Income: -3016559 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3016559 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#260823 Filing: 000114420414014836 The citation records this snapshot. The page link may show a newer release later.	−USD 2.47 million Exact value Exact value: -2468686 USD 2004-01-01 – 2004-12-31: -2468686 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Chelsea Therapeutics International, Ltd. · 2004-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Operating Cash Flow: -2468686 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2468686 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-07-052204.txt#6001 The citation records this snapshot. The page link may show a newer release later.	USD 62,535 Exact value Exact value: 62535 USD 2004-01-01 – 2004-12-31: 62535 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Chelsea Therapeutics International, Ltd. · 2004-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Capital Expenditure: 62535 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 62535 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-07-052204.txt#6055 The citation records this snapshot. The page link may show a newer release later.	−USD 2.53 million Calculation and evidence -2468686 − 62535 USD Exact free cash flow: -2531221 USD 2004-01-01 – 2004-12-31: -2468686 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 62535 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Chelsea Therapeutics International, Ltd. · 2004-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Free cash flow: -2531221 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2468686 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-07-052204.txt#6001 Input fundies:CapitalExpenditure: 62535 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-07-052204.txt#6055 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 7.92 million Exact value Exact value: -7915722 USD 2005-01-01 – 2005-12-31: -7915722 USD Inspect Net Income Open source Share or cite Citation for Net Income · Chelsea Therapeutics International, Ltd. · 2005-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Net Income: -7915722 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7915722 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#261371 Filing: 000114420414014836 The citation records this snapshot. The page link may show a newer release later.	−USD 7.39 million Exact value Exact value: -7387141 USD 2005-01-01 – 2005-12-31: -7387141 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Chelsea Therapeutics International, Ltd. · 2005-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Operating Cash Flow: -7387141 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7387141 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-08-052916.txt#6980 The citation records this snapshot. The page link may show a newer release later.	USD 17,564 Exact value Exact value: 17564 USD 2005-01-01 – 2005-12-31: 17564 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Chelsea Therapeutics International, Ltd. · 2005-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Capital Expenditure: 17564 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 17564 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-08-052916.txt#7034 The citation records this snapshot. The page link may show a newer release later.	−USD 7.4 million Calculation and evidence -7387141 − 17564 USD Exact free cash flow: -7404705 USD 2005-01-01 – 2005-12-31: -7387141 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 17564 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Chelsea Therapeutics International, Ltd. · 2005-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Free cash flow: -7404705 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7387141 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-08-052916.txt#6980 Input fundies:CapitalExpenditure: 17564 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-08-052916.txt#7034 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 8.67 million Exact value Exact value: -8671376 USD 2006-01-01 – 2006-12-31: -8671376 USD Inspect Net Income Open source Share or cite Citation for Net Income · Chelsea Therapeutics International, Ltd. · 2006-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Net Income: -8671376 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8671376 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#261707 Filing: 000114420414014836 The citation records this snapshot. The page link may show a newer release later.	−USD 7.1 million Exact value Exact value: -7101710 USD 2006-01-01 – 2006-12-31: -7101710 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Chelsea Therapeutics International, Ltd. · 2006-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Operating Cash Flow: -7101710 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7101710 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-09-044375.txt#7609 The citation records this snapshot. The page link may show a newer release later.	USD 35,127 Exact value Exact value: 35127 USD 2006-01-01 – 2006-12-31: 35127 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Chelsea Therapeutics International, Ltd. · 2006-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Capital Expenditure: 35127 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 35127 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-09-044375.txt#7663 The citation records this snapshot. The page link may show a newer release later.	−USD 7.14 million Calculation and evidence -7101710 − 35127 USD Exact free cash flow: -7136837 USD 2006-01-01 – 2006-12-31: -7101710 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 35127 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Chelsea Therapeutics International, Ltd. · 2006-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Free cash flow: -7136837 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7101710 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-09-044375.txt#7609 Input fundies:CapitalExpenditure: 35127 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-09-044375.txt#7663 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 15.08 million Exact value Exact value: -15081545 USD 2007-01-01 – 2007-12-31: -15081545 USD Inspect Net Income Open source Share or cite Citation for Net Income · Chelsea Therapeutics International, Ltd. · 2007-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Net Income: -15081545 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15081545 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#262043 Filing: 000114420414014836 The citation records this snapshot. The page link may show a newer release later.	−USD 10.65 million Exact value Exact value: -10651091 USD 2007-01-01 – 2007-12-31: -10651091 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Chelsea Therapeutics International, Ltd. · 2007-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Operating Cash Flow: -10651091 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10651091 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-10-052647.txt#8105 The citation records this snapshot. The page link may show a newer release later.	USD 30,877 Exact value Exact value: 30877 USD 2007-01-01 – 2007-12-31: 30877 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Chelsea Therapeutics International, Ltd. · 2007-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Capital Expenditure: 30877 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 30877 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-10-052647.txt#8159 The citation records this snapshot. The page link may show a newer release later.	−USD 10.68 million Calculation and evidence -10651091 − 30877 USD Exact free cash flow: -10681968 USD 2007-01-01 – 2007-12-31: -10651091 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 30877 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Chelsea Therapeutics International, Ltd. · 2007-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Free cash flow: -10681968 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10651091 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-10-052647.txt#8105 Input fundies:CapitalExpenditure: 30877 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-10-052647.txt#8159 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 35.09 million Exact value Exact value: -35086151 USD 2008-01-01 – 2008-12-31: -35086151 USD Inspect Net Income Open source Share or cite Citation for Net Income · Chelsea Therapeutics International, Ltd. · 2008-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Net Income: -35086151 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -35086151 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#262381 Filing: 000114420414014836 The citation records this snapshot. The page link may show a newer release later.	−USD 22.31 million Exact value Exact value: -22311345 USD 2008-01-01 – 2008-12-31: -22311345 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Chelsea Therapeutics International, Ltd. · 2008-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Operating Cash Flow: -22311345 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22311345 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-11-091390.txt#9215 The citation records this snapshot. The page link may show a newer release later.	USD 175,028 Exact value Exact value: 175028 USD 2008-01-01 – 2008-12-31: 175028 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Chelsea Therapeutics International, Ltd. · 2008-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Capital Expenditure: 175028 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 175028 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-11-091390.txt#9269 The citation records this snapshot. The page link may show a newer release later.	−USD 22.49 million Calculation and evidence -22311345 − 175028 USD Exact free cash flow: -22486373 USD 2008-01-01 – 2008-12-31: -22311345 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 175028 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Chelsea Therapeutics International, Ltd. · 2008-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Free cash flow: -22486373 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22311345 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-11-091390.txt#9215 Input fundies:CapitalExpenditure: 175028 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/0001193125-11-091390.txt#9269 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 25.77 million Exact value Exact value: -25771914 USD 2009-01-01 – 2009-12-31: -25771914 USD Inspect Net Income Open source Share or cite Citation for Net Income · Chelsea Therapeutics International, Ltd. · 2009-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Net Income: -25771914 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25771914 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#263101 Filing: 000114420414014836 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	−USD 37.33 million Exact value Exact value: -37330069 USD 2010-01-01 – 2010-12-31: -37330069 USD Inspect Net Income Open source Share or cite Citation for Net Income · Chelsea Therapeutics International, Ltd. · 2010-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Net Income: -37330069 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -37330069 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#263439 Filing: 000114420414014836 The citation records this snapshot. The page link may show a newer release later.	−USD 32.25 million Exact value Exact value: -32251773 USD 2010-01-01 – 2010-12-31: -32251773 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Chelsea Therapeutics International, Ltd. · 2010-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Operating Cash Flow: -32251773 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -32251773 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420413013609/chtp-20121231.xml#246164 Filing: 000114420413013609 The citation records this snapshot. The page link may show a newer release later.	USD 151,836 Exact value Exact value: 151836 USD 2010-01-01 – 2010-12-31: 151836 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Chelsea Therapeutics International, Ltd. · 2010-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Capital Expenditure: 151836 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 151836 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420413013609/chtp-20121231.xml#246884 Filing: 000114420413013609 The citation records this snapshot. The page link may show a newer release later.	−USD 32.4 million Calculation and evidence -32251773 − 151836 USD Exact free cash flow: -32403609 USD 2010-01-01 – 2010-12-31: -32251773 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 151836 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Chelsea Therapeutics International, Ltd. · 2010-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Free cash flow: -32403609 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32251773 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420413013609/chtp-20121231.xml#246164 Filing: 000114420413013609 Input fundies:CapitalExpenditure: 151836 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420413013609/chtp-20121231.xml#246884 Filing: 000114420413013609 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 50.45 million Exact value Exact value: -50452165 USD 2011-01-01 – 2011-12-31: -50452165 USD Inspect Net Income Open source Share or cite Citation for Net Income · Chelsea Therapeutics International, Ltd. · 2011-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Net Income: -50452165 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -50452165 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#205963 Filing: 000114420414014836 The citation records this snapshot. The page link may show a newer release later.	−USD 48.04 million Exact value Exact value: -48039584 USD 2011-01-01 – 2011-12-31: -48039584 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Chelsea Therapeutics International, Ltd. · 2011-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Operating Cash Flow: -48039584 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -48039584 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#285893 Filing: 000114420414014836 The citation records this snapshot. The page link may show a newer release later.	USD 227,468 Exact value Exact value: 227468 USD 2011-01-01 – 2011-12-31: 227468 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Chelsea Therapeutics International, Ltd. · 2011-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Capital Expenditure: 227468 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 227468 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#286846 Filing: 000114420414014836 The citation records this snapshot. The page link may show a newer release later.	−USD 48.27 million Calculation and evidence -48039584 − 227468 USD Exact free cash flow: -48267052 USD 2011-01-01 – 2011-12-31: -48039584 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 227468 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Chelsea Therapeutics International, Ltd. · 2011-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Free cash flow: -48267052 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -48039584 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#285893 Filing: 000114420414014836 Input fundies:CapitalExpenditure: 227468 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#286846 Filing: 000114420414014836 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 31.74 million Exact value Exact value: -31735909 USD 2012-01-01 – 2012-12-31: -31735909 USD Inspect Net Income Open source Share or cite Citation for Net Income · Chelsea Therapeutics International, Ltd. · 2012-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Net Income: -31735909 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -31735909 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#206102 Filing: 000114420414014836 The citation records this snapshot. The page link may show a newer release later.	−USD 39.37 million Exact value Exact value: -39365952 USD 2012-01-01 – 2012-12-31: -39365952 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Chelsea Therapeutics International, Ltd. · 2012-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Operating Cash Flow: -39365952 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -39365952 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#286131 Filing: 000114420414014836 The citation records this snapshot. The page link may show a newer release later.	USD 25,260 Exact value Exact value: 25260 USD 2012-01-01 – 2012-12-31: 25260 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Chelsea Therapeutics International, Ltd. · 2012-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Capital Expenditure: 25260 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 25260 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#287041 Filing: 000114420414014836 The citation records this snapshot. The page link may show a newer release later.	−USD 39.39 million Calculation and evidence -39365952 − 25260 USD Exact free cash flow: -39391212 USD 2012-01-01 – 2012-12-31: -39365952 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 25260 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Chelsea Therapeutics International, Ltd. · 2012-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Free cash flow: -39391212 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -39365952 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#286131 Filing: 000114420414014836 Input fundies:CapitalExpenditure: 25260 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#287041 Filing: 000114420414014836 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 16.42 million Exact value Exact value: -16416233 USD 2013-01-01 – 2013-12-31: -16416233 USD Inspect Net Income Open source Share or cite Citation for Net Income · Chelsea Therapeutics International, Ltd. · 2013-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Net Income: -16416233 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16416233 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#206241 Filing: 000114420414014836 The citation records this snapshot. The page link may show a newer release later.	−USD 15.01 million Exact value Exact value: -15007254 USD 2013-01-01 – 2013-12-31: -15007254 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Chelsea Therapeutics International, Ltd. · 2013-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Operating Cash Flow: -15007254 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15007254 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#286369 Filing: 000114420414014836 The citation records this snapshot. The page link may show a newer release later.	USD 2,994 Exact value Exact value: 2994 USD 2013-01-01 – 2013-12-31: 2994 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Chelsea Therapeutics International, Ltd. · 2013-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Capital Expenditure: 2994 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2994 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#287235 Filing: 000114420414014836 The citation records this snapshot. The page link may show a newer release later.	−USD 15.01 million Calculation and evidence -15007254 − 2994 USD Exact free cash flow: -15010248 USD 2013-01-01 – 2013-12-31: -15007254 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 2994 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Chelsea Therapeutics International, Ltd. · 2013-12-31 Chelsea Therapeutics International, Ltd. (edgar:1333763) Free cash flow: -15010248 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333763?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15007254 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#286369 Filing: 000114420414014836 Input fundies:CapitalExpenditure: 2994 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333763/000114420414014836/chtp-20131231.xml#287235 Filing: 000114420414014836 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

42 filings · 1,028 latest values · 1,028 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001333763, 1333763, CHTP, chtp, edgar:1333763

Also known as Chelsea Therapeutics International, Ltd.

Chelsea Therapeutics International, Ltd.

Reported share-count change

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation